Clin Osteol 2013; 18(2): 53-59

Risk factors for osteoporosis and the importance of FRAX for primary care physiciansOriginal contributions

S. Tomková, B. Suchá, P. Jackuliak

Osteoporosis is a disease that may be reliably diagnosed, treated and prevented. Improved diagnosis and treatment of osteoporosis should be an important priority of primary care physicians. The article is concerned with a survey of primary care physicians' gene­ ral knowledge of osteoporosis and their awareness of densitometry indications. The general knowledge was ascertained using a ques­ tionnaire on risk factors, drugs and diseases associated with osteoporosis as well as the prevalence and mortality of the condition. The results showed relatively poor general knowledge. There were statistically insignificant differences in knowledge depending on gender, length of practice and size of the settlement. There was inadequate awareness of densitometry indications and insufficient use of questionnaires for early identification of patients with risk factors for osteoporosis. The survey pointed to a need for continuing edu­ cation of physicians in this area. It also suggested that the FRAX questionnaire may be used to determine th res in a particular patient.

Keywords: osteoporosis, riskfactorsfor osteoporosis, primary care physician, education in osteoporosis, FRAX

Published: December 11, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tomková S, Suchá B, Jackuliak P. Risk factors for osteoporosis and the importance of FRAX for primary care physicians. Osteologický bulletin. 2013;18(2):53-59.
Download citation

References

  1. Payer J, Killinger Z a kol. Osteoporóza. Bratislava, Herba 2012; s 264.
  2. Cooper C, Mitchell P, Kanis JA Brea Osteoporosis Int 2011;22(7):2049-2050. Go to original source...
  3. Strom O, Borgstrom F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jonsson B. Osteoporosis: Burden, health care provision and opportunities in t Union. Archives of Osteoporosis 2011. [DOI 10.1007/s11657-011-0060-1] Go to original source...
  4. Kanis JA, McCloskey EV et al. Case finding for the management of osteoporosis with FRAX - assessment and intervention thresholds for the UK. Osteoporosis 2008;19(10):1395-1408. Go to original source...
  5. Odborné usmernenie MZ SR pre diagnostiku a liečbu osteoporózy. Vestník MZ SR 2006;54:9-16.
  6. De Laet C, Odén A, Johansson H, Johnell O, Jonsson B, Kanis JA The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mat matical approach. Osteoporosis Int 2005;16:313-18. Go to original source...
  7. Johnell O, Kanis JA An estimate of the worldwide prevalence and disability as­ sociated with osteoporotic fractures. Osteoporos Int 2006;17(12):1726-1733. Go to original source...
  8. Gehlbach SH, Fournier M, Bigelow C. Recognition of Osteoporosis by Primary Care Physicians. Am J Public Health 2002;92(2):271-273. Go to original source...
  9. Marsh D, Akesson K, Beaton DE et al. Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporosis Int 2011;22(7):2051-2065. Go to original source...
  10. Kanis JA, Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporosis Int 2005;16:229-238. Go to original source...
  11. The North American Menopause Society. 2006. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. The Journal of The North American Menopause Society 2006;13(3):340-367. Go to original source...
  12. NIH: National Institutes of Health. 2006. Osteoporosis and Arthritis: Two Com­ mon but Different Conditions. 2006. Dostupné na: < > http://www.niams.nih.gov/Health_Info/Bone/Osteoporosis/Conditions_Behaviors/osteoporosis_arthritis.pdf
  13. Werner P. Knowledge about osteoporosis: assessment, correlates and outcomes. Osteoporosis Int 2005;16(2):115-127. Go to original source...
  14. Weiss TW, Siris ES, Barrett-Connor et al. Osteoporosis practice patterns in among primary care physicians participating in the NORA study. Osteoporosis Int 2007;18:1473-1480. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.